U.S. equity firm closes yuan-fund eyeing Chinese medical sector

HONG KONG — Vivo Capital, a global health care investment company that has backed Chinese companies such as medical-tech platform WuXi AppTec, has held the first closing of a new yuan-denominated fund at 4 billion yuan ($600 million), with a target of eventually raising about 10 billion yuan.